Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates.
about
Clinical pharmacology of midazolam in neonates and children: effect of disease-a reviewSedation in Critically Ill Children with Respiratory FailurePharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.Tips and traps analyzing pediatric PK data.Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.Feasibility of sedation and analgesia interruption following cannulation in neonates on extracorporeal membrane oxygenation.The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation.Inter-individual variation in midazolam clearance in children.Ketamine infusion for patients receiving extracorporeal membrane oxygenation support: a case seriesInvasiveness of pharmacokinetic studies in children: a systematic reviewScaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models.The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.Anesthesia and analgesia in the NICU.Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenationScaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?A systematic review on pharmacokinetic changes in critically ill patients: role of extracorporeal membrane oxygenation.State of the art: strategies for extracorporeal membrane oxygenation in respiratory failure.Population pharmacokinetic analysis during the first 2 years of life: an overview.Tailored tools to improve pharmacotherapy in infants.Drug metabolism for the paediatrician.Sedation Management in Children Supported on Extracorporeal Membrane Oxygenation for Acute Respiratory Failure.Pharmacological sedation management in the paediatric intensive care unit.Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous hemofiltration.Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.Insufficient serum caspofungin levels in a paediatric patient on ECMO.Determinants of drug absorption in different ECMO circuits.Medication adsorption into contemporary extracorporeal membrane oxygenator circuits.Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures.Antifungal Extraction by the Extracorporeal Membrane Oxygenation Circuit.Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation.A retrospective study of sedation and analgesic requirements of pediatric patients on extracorporeal membrane oxygenation (ECMO) from a single-center experience.High-Dose Sedation and Analgesia During Extracorporeal Membrane Oxygenation: A Focus on the Adjunctive Use of Ketamine.Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics.
P2860
Q27006333-5B01CD84-4762-4023-8CA4-1D1BA1BD07ECQ28080112-8CE80976-0125-4B96-A602-FA547638CA23Q30249512-97A72CBE-822F-4BAC-AD47-381E45D338C6Q33820152-3C4AA453-B12A-41C7-A149-71656FD82B96Q33826426-1FA03E21-1A3F-47F5-B004-9FD2F11513F9Q34063554-AC2F0969-1144-4BFF-9A4B-94CFA1CBA621Q34630847-A5DC4788-1799-444C-BBCD-F3B32E4D361CQ35301181-C940C327-F3D3-4041-BF6D-83413D31D900Q35953787-23CC82CD-DE83-4B0F-BD2B-9752ED062199Q36081153-5B604561-2A82-4F6F-8E79-38B8A07E2AB8Q36336064-CB5046AD-C7BB-40A8-B808-582A2CCF2BA8Q36452379-A27DE619-CB32-47B4-BAE8-B9B50E23F179Q36730497-82568ADE-6774-4D51-8632-8BC2D0ABD620Q36928231-EF47D01A-2EF9-4C6F-9217-84BDBF6CC3E1Q37695055-1D7C78D1-C961-4549-8FDA-6BC6E70C4F82Q38012111-9DEB200E-8002-4994-AF6D-D3434A8120DFQ38058353-B92470FF-E0EC-473B-A92E-CC8BD594D7DBQ38062388-E0DB2820-5893-40A3-8173-7262D0116BD2Q38222870-D2CAF4A1-C7D4-4A9A-80F4-2BD7D0AE4494Q38246000-6CB0DC1A-48AA-41B5-B12F-4B6672E3D628Q38725892-C081A9D9-E8FC-4A1E-B79A-20017310D702Q38829350-02148244-A3CB-47E7-9315-F603D3C6E7A0Q39025601-27B16DC7-6DCA-40AA-8BD1-109397B6A5F8Q39033001-CE22E45B-0DBF-4D57-9C7E-EA0D0C617411Q41860910-4DEF5464-5BBA-4481-B816-26AC898C8711Q42362818-75A20824-3B9B-4167-A4A1-15CDD8B86D1EQ43163797-4CB00978-834A-4204-8E0A-EA151F0AC0CCQ44201200-699FB7FE-511A-4F71-BFE9-623FB9BF3195Q45069269-6DA2674A-14DB-4EEA-BEE0-84F1A84D06E2Q47152342-2763C1CE-0EF3-4283-AF5D-46BEB24D3F31Q47376384-E6C20585-1397-4643-A4D3-F2C908093E70Q47591928-DE0FE4B4-4F0D-47D1-BB8E-28C67DF1292DQ55145216-AD44F06A-81D0-418F-B0B7-F6F555E5983B
P2860
Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Population pharmacokinetics of ...... brane oxygenation in neonates.
@en
Population pharmacokinetics of ...... brane oxygenation in neonates.
@nl
type
label
Population pharmacokinetics of ...... brane oxygenation in neonates.
@en
Population pharmacokinetics of ...... brane oxygenation in neonates.
@nl
prefLabel
Population pharmacokinetics of ...... brane oxygenation in neonates.
@en
Population pharmacokinetics of ...... brane oxygenation in neonates.
@nl
P2093
P2860
P1476
Population pharmacokinetics of ...... mbrane oxygenation in neonates
@en
P2093
Enno D Wildschut
Manon Hanekamp
Ron A A Mathot
P2860
P304
P356
10.2165/11319970-000000000-00000
P577
2010-06-01T00:00:00Z
P6179
1005161729